Institutional investors purchased a net $879.0 thousand shares of THRX during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 75.51% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE BAUPOST GROUP LLC Bought 2.0 Million shares of Theravance Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.3 Million shares of Theravance Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 478.4 Thousand shares of Theravance Inc